Clinical trials
Learning clinical trials
Below are recruiting learning clinical trials, each written for real people, not researchers. We’re tracking 631 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06269939Recruiting
Memory training for healthy aging and mild memory loss
This study tests a special memory training program for people with mild memory problems (MCI) or healthy aging. It aims to improve how you learn and remember new information using guided methods.
East Hanover, New JerseyAges 60 years+ - NCT06722248Recruiting
Simulation learning for new nursing students in maternal care
This trial tests a hands-on simulation learning program for nursing students who are new to caring for mothers and newborns. It helps you practice safely in a realistic setting before working with real patients.
Hong Kong, HksarAges 18–30 - NCT06695663Recruiting
Training and trials to improve child mental health referrals
This study tests a training program for primary care providers (PCCs) and a referral process for parents of young children (ages 3-8). It aims to help families get the right mental health support for their child.
Minneapolis, MinnesotaAges 18–100 - NCT07219043RecruitingPhase 2
Felzartamab for kidney transplant patients with inflammation
This trial tests a drug called felzartamab to see if it can help people who have a type of kidney inflammation after a transplant, even without donor-specific antibodies. It might offer a new treatment option for those who are not getting better on their own.
Loma Linda, CaliforniaAges 18–74 - NCT07535112RecruitingPhase 1
Testing BAY 3771249 for Advanced Colorectal Cancer With KRAS Mutation
This early-stage study tests a new drug called BAY 3771249 in people with advanced colorectal cancer that has a specific genetic change (KRAS G12D mutation). Researchers want to learn if it's safe and whether it helps shrink tumors.
Phoenix, ArizonaAges 18 years+ - NCT07543380RecruitingPhase 3
RSV vaccine safety and immune response in high-risk adults
This study tests a new RSV vaccine designed to protect adults with chronic health conditions from severe RSV disease (a respiratory infection). Researchers will monitor how safe the vaccine is and how well your immune system responds to it.
Tsuchiura, IbarakiAges 18–59 - NCT07283458Recruiting
Testing language learning in children in child psychiatry
This trial uses a tablet app to test how well children in child psychiatry services understand language and learn. It aims to better understand their needs and improve care.
ParisAges 3–7 - NCT05666518Recruiting
Study of vericiguat safety in Japanese chronic heart failure patients
This study checks how safe the medicine vericiguat is for Japanese people with chronic heart failure when used in everyday care. It compares patients who receive vericiguat with patients who continue standard treatments without vericiguat.
Multiple Locations, Many LocationsAges Any age - NCT05890456Recruiting
School program for grades 5–8 with added family and teacher support
This trial tests a school-based program that brings families and teachers more closely together to support students’ emotional and behavior needs. It may help students who are transitioning between school settings and may be at risk for needing special education services.
Eugene, OregonAges 10–16 - NCT07618416Recruiting
Blood Pressure Prediction Before Anesthesia in Older Adults
This study tests a computer model that uses heart-rhythm measurements to predict whether your blood pressure will drop dangerously after anesthesia begins. If accurate, it could help doctors prepare and protect you during surgery.
Beijing, ChinaAges 65 years+ - NCT07652723RecruitingPhase 1
How a new blood-clotting drug affects clotting with and without aspirin
This study tests an experimental drug (BAY3389934) to see how it affects blood clotting and if it's safe. It is given to healthy adults, alone and then with aspirin. It will help researchers understand how the drug works before testing in patients.
Miami, FloridaAges 18–55 - NCT07124754Recruiting
Predicting lymph node spread in early stomach cancer
This study tests if artificial intelligence can predict whether early-stage stomach cancer has spread to lymph nodes. It also evaluates how well doctors assess the cancer. If the technology works, it could help guide treatment decisions.
Shijiazhuang, None SelectedAges 18 years+ - NCT06629779RecruitingPhase 3
Study of Mevrometostat for Advanced Prostate Cancer
This study tests a new drug called mevrometostat for men with a specific type of advanced prostate cancer that has spread and is still growing despite hormone therapy. It aims to see if the drug can help control the cancer.
Chandler, ArizonaAges 18 years+ - NCT07570680Recruiting
Brain Bleeding Stroke AI Decision Support System
This study tests an artificial intelligence system designed to help doctors make better treatment decisions for patients with sudden brain bleeding. The AI analyzes CT scans and patient information to guide care choices during hospitalization.
NanchangAges 8 years+ - NCT06886529Recruiting
Patient and family involvement in cardiology care at SickKids
This study looks at how patients and families can be more involved in care for children admitted to the cardiology unit at SickKids. It may help improve how the hospital works with families.
TorontoAges Up to 18 years - NCT07521111Recruiting
Stomach Blood Flow and Feeding Tolerance in Critical Illness
This study examines whether measuring blood flow in the stomach using ultrasound can predict which hospitalized patients will struggle to tolerate tube feeding. Researchers hope this simple test might help doctors adjust feeding plans earlier and improve patient outcomes.
ShanghaiAges 18 years+ - NCT05886803Recruiting
Predicting breathing test success in the ICU
This study uses data from your hospital records to see if a machine learning tool can predict whether a patient will succeed when doctors try to remove their breathing tube during a test of their own breathing.
NiceAges Any age - NCT07669974Recruiting
Comparing two training methods for robot-assisted prostate surgery
This trial tests two training methods for learning robot-assisted radical prostatectomy (a surgery to remove the prostate using robotic tools). If you are a surgeon taking a specific training course, you may be able to join and help find out which teaching approach works best.
Melle, BelgiumAges Any age - NCT07188597Recruiting
Therapy to help prevent first episode of psychosis
This trial tests a culturally adapted talking therapy to help young people who are at risk of having their first episode of psychosis. If you are between 16 and 35, have some early warning signs but no history of psychosis, this study might be a good fit.
Karachi, SindhAges 16–35 - NCT06478394Recruiting
Blood test for hidden stomach cancer spread
This study tests a new blood test that uses machine learning to find hidden stomach cancer spread (peritoneal metastases) early. It could help people with locally advanced stomach cancer avoid unnecessary surgery.
Shijiazhuang, HebeiAges 18 years+ - NCT06661122Recruiting
Darolutamide with ADT and docetaxel for low-volume metastatic prostate cancer
This study looks at how safe and effective the combination of darolutamide (a tablet), hormone therapy (ADT), and chemotherapy (docetaxel) is for Japanese men with prostate cancer that has spread in a limited way (low volume). It observes people in regular medical care, not in a research setting.
Multiple LocationsAges 18 years+ - NCT06478303Recruiting
Brain circuits for language and movement learning
This study uses brain imaging and stimulation to see how the brain connects language and movement. It may help improve how we learn motor skills and understand language.
Grenoble, GrenobAges 18–40 - NCT06463444RecruitingPhase 1
Precision treatment for inoperable liver cancer
This trial tests a new precision approach for people with liver cancer that cannot be removed by surgery. It uses a computer model to analyze your tumor and genetic information to see if combining HAIC (chemotherapy directly into the liver), lenvatinib (a targeted drug), and a PD-1 inhibitor (immunotherapy) is the right treatment for you.
Wuhan, HubeiAges 18–75 - NCT06965478Recruiting
Vision and drug effects study for adults 18–60
This trial tests how vision works under different conditions. You may be eligible if you are between 18 and 60, have normal or corrected vision, and do not have certain eye conditions, sleep issues, or implants.
Providence, Rhode IslandAges 18–60
Hear when a new Learning trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for learning?
- Yes. Clin2 currently lists 631 recruiting learning studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a learning trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a learning trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.